Principal Securities »

TherapeuticsMD shares owned by Principal Securities

Quarter-by-quarter ownership of TherapeuticsMD (TXMD) shares owned by Principal Securities from 13F filings

Historical chart of Principal Securities investment in TherapeuticsMD

Tip: Access up to 7 years of quarterly data

All positions including TherapeuticsMD held by Principal Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in TherapeuticsMD by Principal Securities

Quarter filed Position value Share count Share price at filing
2024-09-30 $208 126 1.66
2024-06-30 $202 126 1.61
2024-03-31 $289 126 2.29
2023-12-31 $284 126 2.25

More positions owned by Principal Securities

Principal Exchange Traded Us Mega Cp Etf (USMC)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Goldman Sachs Etf Tr Marketbeta Us Eq (GSUS)
Principal Exchange Traded Prin U S Small (PSC)
Microsoft Corporation (MSFT)
Principal Exchange Traded Focused Blue Chi (BCHP)
Ishares Tr Rus 1000 Etf (IWB)
Amazon (AMZN)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Apple (AAPL)
Principal Exchange Traded Prnc Invt Grad (IG)
Principal Exchange Traded Prncpl Vlu Etf (PY)
Goldman Sachs Etf Tr Activebeta Int (GSIE)

View all positions for Principal Securities

Top funds holding TherapeuticsMD

Rubric Capital Management
Clearline Capital
Tejara Capital
BlackRock
Geode Capital Management
Northern Trust
Citadel Advisors
National Bank Of Canada /fi/
Capital Performance Advisors
Bank of America Corporation
Jpmorgan Chase & Co
Us Bancorp
Royal Bank of Canada
Wells Fargo & Company
Principal Securities

View all funds holding TherapeuticsMD